In recent years, long noncoding RNAs (lncRNAs) have been shown to have critical roles in a broad range of cell biological processes. However, the activities of lncRNAs during ischemic stroke remain largely unknown. In this study, we carried out a genome-wide lncRNA microarray analysis in rat brains with ischemia/reperfusion (I/R) injury. The results revealed the differential expression of a subset of lncRNAs. Through the construction of lncRNA-mRNA co-expression networks, we identified lncRNA-N1LR as a novel I/R-induced lncRNA. The functions of lncRNA-N1LR were assessed by silencing and overexpressing this lncRNA in vitro and in vivo. We found that lncRNA-N1LR enhanced cell cycle progression and cell proliferation, and inhibited apoptosis in N2a cells subjected to in vitro ischemia (oxygen-glucose deprivation/reoxygenation, OGD/R). Furthermore, we showed that lncRNA-N1LR reduced neuronal apoptosis and neural cell loss in I/R-induced mouse brains. Mechanistically, we discovered that lncRNA-N1LR promoted neuroprotection probably through the inhibition of p53 phosphorylation on serine 15 in a manner that was independent of its location-associated gene Nck1. In summary, our results indicated that lncRNA-N1LR promoted neuroprotection against ischemic stroke probably by inactivating p53. Thus, we propose that lncRNA-N1LR may serve as a potential target for therapeutic intervention following ischemic brain injury.
Hypoxia
can increase the resistance of tumor cells to radiotherapy
and chemotherapy. However, the dense extracellular matrix, high interstitial
fluid pressure, and irregular blood supply often serve as physical
barriers to inhibit penetration of drugs or nanodrugs across tumor
blood microvessels into hypoxic regions. Therefore, it is of great
significance and highly desirable to improve the efficiency of hypoxia-targeted
therapy. In this work, living photosynthetic bacteria (PSB) are utilized
as hypoxia-targeted carriers for hypoxic tumor therapy due to their
near-infrared (NIR) chemotaxis and their physiological characteristics
as facultative aerobes. More interestingly, we discovered that PSB
can serve as a kind of photothermal agent to generate heat through
nonradiative relaxation pathways due to their strong photoabsorption
in the NIR region. Therefore, PSB integrate the properties of hypoxia
targeting and photothermal therapeutic agents in an “all-in-one”
manner, and no postmodification is needed to achieve hypoxia-targeted
cancer therapy. Moreover, as natural bacteria, noncytotoxic PSB were
found to enhance immune response that induced the infiltration of
cytotoxicity T lymphocyte. Our results indicate PSB specifically accumulate
in hypoxic tumor regions, and they show a high efficiency in the elimination
of cancer cells. This proof of concept may provide a smart therapeutic
system in the field of hypoxia-targeted photothermal therapeutic platforms.
Emerging clustered regularly interspaced short palindromic repeat/associated protein (CRISPR/Cas) genome editing technology shows great potential in gene therapy. However, proteins and nucleic acids suffer from enzymatic degradation in the physiological environment and low permeability into cells. Exploiting carriers to protect the CRISPR system from degradation, enhance its targeting of specific tissues and cells, and reduce its immunogenicity is essential to stimulate its clinical applications. Here, the authors review the state-of-the-art CRISPR delivery systems and their applications, and describe strategies to improve the safety and efficacy of CRISPR mediated genome editing, categorized by three types of cargo formats, that is, Cas: single-guide RNA ribonucleoprotein, Cas mRNA and single-guide RNA, and Cas plasmid expressing CRISPR/Cas systems. The authors hope this review will help develop safe and efficient nanomaterial-based carriers for CRISPR tools.
The use of glycoside prodrugs is
a promising strategy for developing
new targeted medicines for chemotherapy. However, the in vivo utility of such prodrugs is hindered by insufficient activation
and the lack of convenient synthetic methods. We have developed an
innovative strategy for synthesizing ketal glycoside prodrugs that
are unique in being activated by a dual enzyme- and acid-triggered
self-immolative mechanism. Amphiphilic glucosyl acetone-based ketal-linked
etoposide glycoside prodrug isomers were synthesized and fabricated
into excipient-free nanoparticles for effective cancer prodrug monotherapy.
Hydrolysis of the glycosidic linkage or the ketal linkage triggered
hydrolysis of the other linkage, which resulted in spontaneous self-immolative
hydrolysis of the prodrugs. Nanoparticles of the prodrug isomer that
was the most labile in a lysosome-mimicking environment displayed
high intratumoral accumulation and strong antitumor activity in an
A549 xenograft mouse model. Our strategy may be useful for the development
of stimulus-responsive self-immolative prodrugs and their nanomedicines.
Paclitaxel (Ptx), a type of microtubule depolymerization inhibitor, is one of the main components in gastric cancer chemotherapy. Some studies have demonstrated that tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, has potential antitumor effects in several cancers. Aside from the direct anticancer effect, Tet is proved to synergistically enhance the antitumor effect of Ptx in gastric cancer. However, the application of the combinational strategy is limited by the poor solubility of both drugs. Nanodrug delivery systems including polymeric nanoparticles, selfassembled nanofibers, hydrogels, etc., hold the potential to meet the need. Here, a novel supramolecular nanomaterial, based on the concept of "carrier-free nanodrugs", is reported as a feasible platform for synergistic drug delivery. Ptx−SA−RGD is obtained through the conjugation of Ptx and the tumor-specific peptide RGD (arginine−glycine−aspartic acid) with succinic acid (SA) as a linker. Ptx−SA−RGD could self-assemble into Ptx nanofibers (P-NFs) with high drugloading efficiency. Tet was then encapsulated into P-NFs to acquire novel Ptx and Tet coloaded self-assembled nanofibers (P/T-NFs). The uptake study shows the dynamic internalization of P/T-NFs by the gastric cancer cell line MGC-803. P/T-NFs significantly triggered the accumulation of reactive oxygen species (ROS) in gastric cancer cells MGC803 and further decreased the mitochondrial membrane potential, which led to the induction of mitochondrial apoptosis with superior cytotoxicity against free drugs. Moreover, P/T-NFs suppressed the expressions of p-STAT3 and p-JAK, initiated cytochrome-C release, and promoted caspase protein expression. Furthermore, P/T-NFs demonstrated the strongest tumor-delaying effect as well as the lowest toxicity. Therefore, self-assembled nanofibers of P/T-NFs demonstrated an increase of the mitochondrial apoptosis level and a stronger antitumor effect both in vitro and in vivo, which could be a potential way to enhance the clinical efficacy and reduce the side-effects of Ptx in gastric cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.